Azenta, Inc.
Azenta, Inc. (Nasdaq: AZTA) provides sample exploration and management solutions for the life sciences industry, serving pharmaceutical and biotechnology companies, research hospitals, startups, academic institutions and government organizations. Its offerings support samples from procurement through storage, analysis… From the company’s description.
Over the twelve months to Jun 30, 2026, Azenta, Inc. reported revenue of $613.57M, up 17.5% from a year earlier, and a net loss of $122.94M. Its operating margin was −28.7%, and operations generated $37.98M in cash. In fiscal 2025, it reported revenue of $593.82M, up 3.6% from fiscal 2024, and a net loss of $55.76M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Azenta, Inc. does
In the company’s own words
Azenta, Inc. (Nasdaq: AZTA) provides sample exploration and management solutions for the life sciences industry, serving pharmaceutical and biotechnology companies, research hospitals, startups, academic institutions and government organizations. Its offerings support samples from procurement through storage, analysis and transport, and include automated and cryogenic storage systems, sample repository services, tubes, consumables, instruments, informatics software and genomic services. The company operates two reportable segments: Sample Management Solutions, which provides end-to-end sample management products and services, and Multiomics, which provides gene sequencing, gene synthesis and related sample analysis services. Its customers use these products and services in research, clinical development and commercialization, including work in cell and gene therapy, antibody development and biomarker discovery. Azenta has approximately 14,000 customers globally and employs about 3,000 people and contingent workers as of September 30, 2025. Founded in 1978 as an automation provider to the semiconductor industry, the company sold its last semiconductor business in 2022 and now operates as a life sciences company. Its website is www.azenta.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Industrial Machinery
- Headquarters
- BURLINGTON, MA
- Fiscal year end
- September
- CIK
- 933974
- SIC
- 3559
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Azenta, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Azenta, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Azenta, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Azenta, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Azenta, Inc.'s last four quarterly filings that the numbers alone won't show?”